25Jun 2022
A pilot study on oral cyclosporine A in association with fulguration for the treatment of interstitial cystitis with Hunner's lesions

A pilot study on oral cyclosporine A in association with fulguration for the treatment of interstitial cystitis with Hunner's lesions

To evaluate the efficacy and safety of lesion fulguration in combination with cyclosporine A (CyA) as maintenance therapy in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) with Hunner's lesion (HL). Oral CyA seems to allow a sustained long‐term relief following HL fulguration by alleviating pain, decreasing urinary symptoms, and procuring significant subjective improvement. The daily low dose of 1.5 mg/kg or more minor appears to have limited adverse events while preventing repeated procedures. More extensive trials are warranted.

  • #urology

Like

Save

Share